ALL PRODUCTS (1296 Offers)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Somatropin (191aa) Lyophilized recombinant human growth hormone
20 IU per vial
Form Lyophilized Powder
Packaging 1 Kit (10 × 2 mL Vials)
Estimated Half-Life Approximately 2–3 Hours
Detection Up to 1–2 Days
Primary Mechanism GH Receptor Agonism / IGF-1 Induction
GH / IGF-1 Impact High
Product Information
Dragon PharmaCompound Details
Active Substance Gonadorelin (GnRH) Lyophilized gonadotropin-releasing hormone analogue
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Limited human data · short-acting
Detection Limited data · Up to several weeks
Primary Mechanism GnRH Receptor Agonism (Pulsatile)
HPTA / Gonadotropin Support High (limited human data)
Product Information
Dragon PharmaCompound Details
Active Substance B7-33 Lyophilized single-chain relaxin-2 analogue (RXFP1 agonist)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 6 Minutes (in vitro serum)
Detection Limited data · Up to several weeks
Primary Mechanism RXFP1 Agonism (Relaxin Receptor)
Anti-Fibrotic / Tissue Remodeling Impact High (preclinical)
Product Information
Dragon PharmaCompound Details
Active Substance Bronchogen Lyophilized bioregulatory peptide (Khavinson, lung-targeted)
20 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Limited human data · short-acting
Detection Limited data · Up to several weeks
Primary Mechanism Proposed Bronchial Gene-Expression Modulation
Cellular / Regenerative Impact Low (limited human data)